News Releases

Paul J. Mather, MD, a cardiologist and a professor of Clinical Medicine in the Perelman School of Medicine at the University of Pennsylvania, has been named the American Heart Association’s (AHA) 2020 Physician of the Year.

The majority of commercially insured patients who visited the emergency department (ED) for an opioid overdose didn’t receive the timely follow-up care known to help prevent a future overdose or death, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.

Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.

After examining data from large trials of autoimmune-disease medications called Interleukin-17 (IL-17) inhibitors, researchers at the Perelman School of Medicine at the University of Pennsylvania found individuals who took these treatments were about 30 to 60 percent more likely to develop symptoms associated with respiratory-tract infections.